1. Home
  2. ABCL vs PCT Comparison

ABCL vs PCT Comparison

Compare ABCL & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • PCT
  • Stock Information
  • Founded
  • ABCL 2012
  • PCT 2015
  • Country
  • ABCL Canada
  • PCT United States
  • Employees
  • ABCL N/A
  • PCT N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • PCT Environmental Services
  • Sector
  • ABCL Health Care
  • PCT Utilities
  • Exchange
  • ABCL Nasdaq
  • PCT Nasdaq
  • Market Cap
  • ABCL 719.0M
  • PCT 1.6B
  • IPO Year
  • ABCL 2020
  • PCT N/A
  • Fundamental
  • Price
  • ABCL $2.68
  • PCT $9.98
  • Analyst Decision
  • ABCL Buy
  • PCT Buy
  • Analyst Count
  • ABCL 3
  • PCT 5
  • Target Price
  • ABCL $11.00
  • PCT $6.13
  • AVG Volume (30 Days)
  • ABCL 1.6M
  • PCT 2.0M
  • Earning Date
  • ABCL 11-04-2024
  • PCT 11-06-2024
  • Dividend Yield
  • ABCL N/A
  • PCT N/A
  • EPS Growth
  • ABCL N/A
  • PCT N/A
  • EPS
  • ABCL N/A
  • PCT N/A
  • Revenue
  • ABCL $33,054,000.00
  • PCT N/A
  • Revenue This Year
  • ABCL N/A
  • PCT N/A
  • Revenue Next Year
  • ABCL $44.70
  • PCT $494.98
  • P/E Ratio
  • ABCL N/A
  • PCT N/A
  • Revenue Growth
  • ABCL N/A
  • PCT N/A
  • 52 Week Low
  • ABCL $2.34
  • PCT $2.39
  • 52 Week High
  • ABCL $6.06
  • PCT $10.68
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 55.91
  • PCT 63.29
  • Support Level
  • ABCL $2.43
  • PCT $9.16
  • Resistance Level
  • ABCL $2.62
  • PCT $10.65
  • Average True Range (ATR)
  • ABCL 0.11
  • PCT 0.59
  • MACD
  • ABCL 0.02
  • PCT -0.02
  • Stochastic Oscillator
  • ABCL 94.74
  • PCT 66.75

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About PCT PureCycle Technologies Inc. Common stock

PureCycle Technologies Inc holds a license to commercialize the only patented solvent-based purification recycling technology, developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene (PP) into a virgin-like resin. The proprietary process removes color, odor, and other contaminants from recycled feedstock resulting in virgin-like polypropylene suitable for any PP market.

Share on Social Networks: